Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT05417971
Reduced Intensity Fludarabine and TBI Prior to Haplo-Identical Transplantation
Sponsor: Northside Hospital, Inc.
View on ClinicalTrials.gov
Summary
This trial will evaluate the safety and efficacy of RIC HIDT transplant protocol following fludarabine and intermediate-dose TBI 800 cGy utilizing PBSC as the stem cell source.
Official title: A Phase II Trial of Reduced Intensity Fludarabine and Total Body Irradiation-Based Conditioning Prior to Haplo-Identical Transplantation for Patients With Hematologic Malignancies
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
20
Start Date
2022-08-29
Completion Date
2026-12-31
Last Updated
2025-10-30
Healthy Volunteers
No
Conditions
Interventions
OTHER
Fludarabine
Reduced-intensity fludarabine with intermediate-dose TBI
Locations (1)
Caitlin Guzowski
Atlanta, Georgia, United States